as on October 31, 2025 at 1:29 am IST
Day's High
8.70%
Upside

52 Week's Low
52 Week's High

33.33%
Downside
555.07%
Upside

Check Bioline Rx Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.7M
EPS (TTM)
-0.795
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0.2
Return On Equity TTM
-45.94%
Compare market cap, revenue, PE, and other key metrics of Bioline Rx Ltd with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| NA | $15.7M | -95.64% | NA | -45.34% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| NA | $36.1B | NA | NA | -3.89% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Bioline Rx Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioline Rx Ltd investment value today
Current value as on today
₹26,690
Returns
Returns from Bioline Rx Ltd Stock
Dollar Returns*
₹5,667 (+5.67%)
Search interest for Bioline Rx Ltd Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:21% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.6% return, outperforming this stock by 159.3%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.4% return, outperforming this stock by 222.1%
 NEGATIVE IMPACT
NEGATIVE IMPACTPrice Dip

In the last 1 year, BLRX stock has moved down by -78.7%
| Organisation | Bioline Rx Ltd | 
| Headquarters | Modi?in Technology Park, Hevel Modi'in, Israel, 7177871 | 
| Industry | Health Technology | 
| CEO | Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Ella Sorani Ph.D. | Chief Development Officer | 
| Mr. John Lacey | Head of Corporate Communications & Investor Relations | 
| Mr. Raziel Fried | Treasurer & Budgetary Control Director | 
| Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA | Chief Executive Officer | 
| Ms. Mali Zeevi CPA, CPA | Chief Financial Officer | 
Bioline Rx Ltd share price today is $3.45 as on at the close of the market. Bioline Rx Ltd share today touched a day high of $3.75 and a low of $3.45.
Bioline Rx Ltd share touched a 52 week high of $22.6 on and a 52 week low of $2.3 on . Bioline Rx Ltd stock price today i.e. is closed at $3.45,which is 84.73% down from its 52 week high and 49.99% up from its 52 week low.
Bioline Rx Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Bioline Rx Ltd (BLRX) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Bioline Rx Ltd stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Bioline Rx Ltd share’s latest price of $3.45 as on October 31, 2025 at 1:29 am IST, you will get 2.8986 shares of Bioline Rx Ltd. Learn more about
          
            fractional shares .
        
Bioline Rx Ltd stock has given -95.64% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?